Ga q and Ga 11 signalling pathways contribute to cardiac diseases such as hypertrophy and arrhythmia, but their role in cardiac myocytes from healthy hearts has remained unclear. We aimed to investigate the contribution of Ga q and Ga 11 signalling to the basal properties of ventricular myocytes.
Methods and results
We created a conditional Ga q knockout (KO) after tamoxifen injection into gnaq flox/flox gna11 2/2 a-MHC Cre tg/0 mice and found alterations in the electrophysiological and Ca 2+ handling properties of ventricular myocytes using patch-clamp and Fura-2 video imaging. To reveal the genuine effects of protein KO, we investigated the individual contributions of (i) tamoxifen injection, (ii) Cre recombinase expression, (iii) Ga 11 KO, and (iv) Ga q KO. Profound and persistent alterations in myocyte properties occurred following the tamoxifen injection alone. Consequently, we used the presence or absence of Cre recombinase expression as the determinant for the Ga q KO. Myocytes from the Ga q and/or Ga 11 KO mice displayed genuine alterations in the action potentials, membrane capacitance, membrane currents, and Ca 2+ handling (amplitude, post-rest behaviour, and Ca 2+ removal processes).
Conclusions
We conclude that, in a transgenic model, the role of Ga q can be best studied using Cre recombinase expression as the molecular determinant for Ga q KO rather than tamoxifen/miglyol injection. While excessive hormonal stimulation of the Ga q /Ga 11 signalling pathways plays an essential role in cardiac diseases, we propose that the persistent low-level stimulation of these pathways by Ga q /Ga 11 activation is instrumental in the physiological behaviour of ventricular myocytes.
Introduction
Members of the heterotrimeric G-protein family mediate both acute and chronic cardiac responses. 1, 2 Within the G-protein family, the role of Ga q and Ga 11 (Ga q/11 ) in the acute physiological response of cardiomyocytes is not fully understood. 3 -7 Moreover, an involvement of Ga q/11 in the regulation of myocyte contractility via cross talk to b-adrenergic Ga s signalling has been proposed. 8 -11 The role of Ga q/11 in chronic pathological responses, including the development of cardiac hypertrophy, has been established using genetically modified mouse models. 12, 13 Transgenic mice overexpressing Ga q showed an increased expression of hypertrophic marker genes. 14 In contrast, the inhibition of Ga q/11 via the expression of a 54-amino acid Ga q/11 -inhibitory peptide diminished pressure-overload-induced cardiac hypertrophy. 15 A heart-specific inactivation of Ga q/11 abolished the hypertrophic responses to pressure overload. 13 The over-expression of the GTPase activating protein RGS4, which accelerates Ga q and Ga 11 inactivation, reduced pressure-overload-induced cardiac hypertrophy. 16 Previously, the knockout (KO) of Ga q and/or Ga 11 was achieved by noninducible approaches. Even though the KO might have been tissuespecific, the gene deletion occurred early in development enabling compensatory mechanisms to prevail and possibly obscure the KO effect. † The authors contribute equally to this work Surprisingly, few studies took into consideration that the modulation of Ga q or Ga 11 levels itself might affect the physiology of cardiac myocytes, including Ca 2+ handling and electrophysiological properties. 17, 18 Nevertheless, it appears imperative to understand such interactions to fully appreciate Ga q/11 KO in disease models.
In the current study, we investigated the contribution of 
Preparation of isolated ventricular myocytes
The isolation protocol was adapted from a procedure for rat cardiomyocytes. 21 
Western blot analysis
Freshly isolated cells were used for preparation of protein extracts. Proteins were separated on 10% SDS -PAGE and electrophoretically transferred to PVDF membrane. Blots were probed with corresponding primary and secondary antibodies to detect proteins of interest. For details, see Supplementary material online. We used the Cre mouse described in the method section (see also Supplementary material online, Figure S1 ) to generate a cardiacspecific Ga q KO. We performed the Ga q KO on a Ga 11 -deficient background because Ga q and Ga 11 might have overlapping functions. 20 We accomplished this using Gq fl G11
2 Cre + mice (for abbreviations see Table 1 ) and compared animals that were injected with tamoxifen (Ga q/11 double knockout, DKO) to those without tamoxifen induction (Ga 11 KO). Ventricular myocytes were characterised by measuring basic electrophysiological properties with patch-clamp techniques and their global Ca 2+ handling with an established post-rest protocol ( Figure 1 and Supplementary material online Figure S2 ). When analysing APs, we found that in the Ga q/11 DKO, the resting membrane potential (V R ) was unchanged ( Figure 1B) while the amplitude of the APs ( Figure 1C ) was significantly increased, and cells displayed a lower membrane capacitance (C M , Figure 1A ). Figure 1Da details two exemplified APs from each population and indicates that, in addition to the amplitude, the time course of repolarisation appeared prolonged in the Gq fl G11 2 Cre + Tam + cells. This observation was obtained by measuring and analysing APD 30 (early phase of repolarization) and APD 70 (late phase of repolarization). Figure 1Db illustrates the significant prolongation of APD 70 . The repolarisation of the AP is determined by a multitude of potassium currents of which a few might reportedly be under the control of Ga q/ 11 -dependent signalling. 22, 23 It was indicated recently that the Ga 11
protein might be essential in the regulation of the transient outward potassium current (I to ). 17 We therefore investigated I to ( Figure 1E ).
Due to our experimental approach, I to might be contaminated with L-type Ca 2+ current (I Ca ), therefore we refer to it as I toc (see Supplementary material online). Because I toc was significantly reduced in the Ga q/11 DKO cells, we concluded that Ga q KO altered the electrophysiological properties of Ga 11 -deficient cardiomyocytes.
In a second set of experiments, we analysed the global Ca 2+ transients to study the properties of global Ca 2+ homoeostasis ( Figure 1F ).
We decided to use a post-rest protocol (see Supplementary material online, Figure S2 ) because such a stimulation regime allows for the simultaneous investigation of many parameters involved in Ca 2+ hand- Figure 1Fb ), post-rest behaviour was unaltered (PRB in Figure 1Fb ). As a global indicator for the alterations in the apparent activity of the Ca 2+ removal mechanisms, we compared the duration of the Ca 2+ transient at 80% recovery (CTD 80 , Figure 1Fc ) and found a slight (13%) but significant prolongation of the Ca 2+ transient under steady-state conditions. Despite these results, we were concerned whether all the effects were genuinely caused by Ga q KO or whether tamoxifen injection, a lack of Ga 11 and/or Cre expression per se might contribute to the observed phenotypes. Therefore, we designed experiments that specifically addressed: (i) the impact of tamoxifen, (ii) the effects of Cre expression, (iii) the effects of Ga 11 -KO, and (iv) which genotypes are the best for studying the effect of Ga q KO?
Tamoxifen and Ga 11 KO alter the properties of myocytes
Cre recombinase-induced changes in the protein expression profiles of transgenic animals have become an invaluable tool in many areas of research, 24 but the possible interactions with the tamoxifen injection were rarely taken into account. This appeared surprising because changes in gene expression have already been described for chronic treatments in small rodents. 25 We used injections of tamoxifen on five consecutive days followed by 30 days without tamoxifen treatment (the Ga q protein was virtually absent after 25 days as probed by western blot analysis, see Supplementary material online, Figure S1 ). All experiments were carried out in the absence of the drug. Therefore, we studied the putative effects of our standard tamoxifen injection regime on a Ga 11 wild-type (wt) background (Gq wt G11 wt Cre 2 ). To further investigate whether the tamoxifen effects might depend on the genetic background, we also included Gq fl G11 2 Cre 2 animals in our study ( Figure 2) . In control experiments, we found no alterations caused by the insertion of the loxP sites for all parameters we studied (data not shown). Therefore, there was no difference between the Gq fl and Gq wt animals, which allowed us to directly compare the two groups. While in Ga 11 KO animals, C M was reduced (Figure 2A ), V R and AP amplitude were unaltered ( Figure 2B and C, respectively). When we analysed the time course of cellular APs, the findings became rather complex ( Figure 2D ). In wt animals (Gq wt G11 wt Cre 2 ), tamoxifen injection did not change the AP properties (compare the brown and grey APs/bars in Figure 2D ). In contrast, following tamoxifen injection in the Ga 11 KO myocytes (Gq fl G11 2 Cre 2 ), AP repolarization was significantly prolonged both in the early and later phases (APD 30 and APD 70 , compare the violet and green APs/bars in Figure 2D ). Moreover, the KO of the Ga 11 protein resulted in a shortening of the AP repolarisation (compare the brown and violet APs/bars in Figure 2D ). We also investigated I toc ( Figure 2E ) and found alterations among the experimental conditions. These changes were in agreement with the time course of the AP repolarisation. The observed AP shortening following the Ga 11 KO (the brown vs. violet) and the AP prolongation after tamoxifen injection in Gq fl G11 2 Cre 2 mice (the violet vs. green) were accompanied by an increase and decreased in the I toc activity, respectively ( Figure 2Eb ). Ca 2+ signalling also underwent complex changes ( Figure 2F ). Figure 2Fc ). From these findings we concluded: (i) tamoxifen injection resulted in a rather complex, genotype-dependent alteration of electrophysiological properties and Ca 2+ handling even though its injection had been terminated at least 30 days prior to the actual experiment; and (ii) Ga 11 KO altered the electrophysiological properties of ventricular myocytes and their Ca 2+ handling. Table S2 .
Role of Ga q and Ga 11 in ventricular cardiomyocytes Table S2 .
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Cre recombinase expression causes only minor changes in myocyte properties
We then investigated whether the Cre expression exerted effects on properties of the wt (Gq wt G11 wt ) and Ga 11 KO (Gfl   G11 2 ) myocytes, since sole effects of Cre expression have been reported. 26 The results are summarised in Figure 3 . It has to be mentioned that the boxes or bars with identical colours represent the same data set and were replotted if necessary (the brown and violet in Figures 2 and 3 and the red in Figures 1 and 4) . The only electrophysiological parameter that was affected by the Cre expression was the apparent magnitude of the I toc in the Ga 11 -deficient mice (compare the turquoise and violet in Figure 3E ). Interestingly, this Cre-induced decrease in I toc did not change the APD 30 and APD 70 (Figure 3Db) .
Similarly, the Ca 2+ handling was also only slightly affected by the Cre expression ( Figure 3F ). The presence of the Cre recombinase shortened the duration of the first Ca 2+ transient after rest (compare the brown and orange group in Figure 3Fc ). All other significant changes were due to the Ga 11 KO rather than the Cre expression.
From these results, we concluded that the Cre expression did not greatly alter the properties of ventricular myocytes.
Two sets of genotypes are sufficient to study the Ga q/11 KO in ventricular myocytes
The experimental series introduced in Figures 2 and 3 were conducted to evaluate the putative effects of tamoxifen injection, the Ga 11 KO and Cre expression on the basic electrophysiological properties as well as the Ca 2+ handling of ventricular myocytes. The major conclusions were that tamoxifen injection and Ga 11 KO resulted in severe alterations in these properties, but Cre expression only demonstrated small changes. Additionally, in control experiments, we found that the insertion of the loxP sites did not alter the properties studied at all (data not shown). Therefore, we concluded that the tamoxifen/ miglyol injection on a constant genetic background, similar to what we introduced in Figure 1 , was not the best approach to study the effects of Ga q KO on ventricular myocytes. Rather, Cre or loxP insertion would better serve that purpose. Therefore, we designed two genetic approaches to address the role of Ga q ; they are summarised in Tables 2 and 3. The basic idea behind Table 2 was to generate Ga q KO by inserting the loxP sites, while Table 3 introduces the idea of Cre expression. While loxP insertion would require the breeding of four separate mouse lines with an increasing genetic distance over time, the genotypes introduced in Table 3 (Cre expression with tamoxifen injection) would require the breeding of only two mouse lines, enabling us to compare the Ga q KO effects in litter mates. Therefore, we decided to perform the final set of experiments using the genotypes detailed in Table 3 , which all included tamoxifen injection.
Ga q KO results in altered properties of cardiomyocytes, but its consequences depend on Ga 11 expression
When using the genotypes shown in Table 3 , we found that a plethora of electrophysiological properties were changed ( Figure 4A-E) . In the presence of Ga 11 ( Figure 4A -C, the black and blue groups), Ga q KO resulted in an increase in AP amplitude and more negative V R . Such changes could not be observed in the Ga 11 -deficient myocytes ( Figure 4A -C, the green and red groups).
In contrast to most of the interventions introduced so far, when investigating myocytes from our optimized genotype cohort, we did not notice any significant changes in the AP time course ( Figure 4D ) despite significant but minor alterations in I toc ( Figure 4E ). While Ga 11 KO alone resulted in an increased I toc ( Figure 4E , the black vs. green group), the additional KO of Ga q shifted the activity of I toc back to 'control' levels, i.e. towards the currents found in the Gq fl G11 wt Cre 2 Tam + mice ( Figure 4E , the red vs. black groups).
The detailed analysis of Ca 2+ handling in these genotypes revealed a rather complex picture ( Figure 4F ). All genetic interventions, Ga q KO in the presence ( Figure 4F , the green vs. red) and absence of Ga 11 ( Figure 4F , the black vs. blue) as well as the Ga 11 KO alone ( Figure 4F , the black vs. green), altered Ca 2+ handling. For some parameters, the interventions even altered parameters in opposite directions. KO of both the Ga 11 and the Ga q proteins resulted in an increase in the amplitudes of the Ca 2+ transients, but the steady-state parameter was affected much less than the post-rest values ( Figure 4Fb ). These responses resulted in a severe increase in post-rest potentiation (Figure 4Fb, right) . The recovery of the Ca 2+ transients (CTD 80 , Figure 4Fc ) displayed a speed-up after Ga q was deleted in the presence of Ga 11 ( Figure 4Fc , the black vs. blue), but a slowdown or no changes were observed after Ga q deletion in the absence of Ga 11 ( Figure 4Fc , the green vs. red).
From these results, we concluded that Ga q and Ga 11 KO were important determinants of the electrophysiological properties of ventricular myocytes but play an even more exaggerated role in Ca 2+ handling under basic, physiological conditions.
Discussion

A novel heart-specific Cre recombinase mouse line
The creation of transgenic mice expressing Cre recombinase under the control of the a-MHC promoter was a milestone in cardiac research. 27, 28 The employed Cre/loxP technology allowed the control of defined genetic alterations in a temporal and tissue-specific manner. Recent publications emphasized the need of proper controls when using the Cre/loxP technology due to system-inherent pitfalls. 25, 26, 29 The most popular Cre mice in cardiac research studies was created by Sohal et al. 28 But these Cre mice showed abnormalities such as a decreased fractional shortening, increased end-diastolic diameter, and decreased SERCA expression. 25, 26 Here, we employed a novel Cre mouse (Takefuji et al., 2012, submitted for publication) to induce a conditional Ga q KO. To induce Ga q KO, we administered tamoxifen intraperitoneally for five consecutive days (40 mg/kg body weight). The expression of the Ga q protein diminished after 25 days as verified by western blot analysis (Supplementary material online, Figure S1 ). Although Sohal et al. 28 typically used lower tamoxifen doses (20 mg/kg body weight), Koitabashi et al. reported this to be inefficient for protein knockdown. 25 Considering that 50% of the initial tamoxifen concentration is eliminated from the mouse within around 5 days, 30 we assume that at the end of our waiting period of at least 30 days the tamoxifen concentration was below 2% of its starting value. Table S2 . For both parameters, we initially found significant alterations (Figure 1 ), but we were concerned whether our results could be tempered by the possible genomic effects of tamoxifen injection and/or Cre expression.
We investigated these interventions and found that tamoxifen injection, besides its well-known acute effect, 32 did cause long-lasting alterations in APs and Ca 2+ handling (Figure 2 ).
Tamoxifen and its important metabolite 4-hydroxytamoxifen exert both the genomic and non-genomic effects. Alterations of numerous ionic currents as well as inhibition of sarcoplasmic reticulum (SR) Ca 2+ uptake have been associated with acute (non-genomic) effects of tamoxifen application. 33 -35 Genomic tamoxifen effects result in long-lasting modulations of gene expression of ion channels, including potassium channels, e.g. I to , the rapid delayed rectifier current (I Kr aka HERG), the steady-state potassium current (I SS ), and the inward rectifier current (I K1 ). 33 It has to be mentioned here that the latter report applied a chronic tamoxifen treatment (60 days). This does not reflect the usual tamoxifen treatment for inducible KO studies, including our own. The effects we describe here originate from a relatively brief tamoxifen treatment and prevail more than four weeks after termination of the treatment. At this time point, the tamoxifen concentration is believed to be less than 2% of its initial concentration (see above). Tamoxifen injection also caused opposite effects depending on the particular genetic background (e.g. APD in Figure 2Db ). Although we did not investigate this further, we found that such changes were in good agreement with the current density of I toc ( Figure 2E ). We also found profound changes in Ca 2+ handling extending to both their amplitude and recovery phase. Both parameters displayed a rather complex relationship with respect to Ga q / 11 -KO. The KO of Ga q resulted in an acceleration of recovery (decrease in CTD 80 ) in the presence of Ga 11 (Figure 4Fc) , while the same KO displayed reversed effects in the absence of Ga 11 ( Figure 4Fc ). The major processes responsible for the Ca 2+ removal are the sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase (SERCA) pump and the Na + /Ca 2+ exchanger (NCX). Since acute tamoxifen application inhibited SERCA, 35 we might speculate that changes in SERCA activity or expression might underlie the alterations in CTD 80 . Therefore, we suggest that tamoxifen caused long-term changes in gene expression that also manifested in altered Ca 2+ handling ( Figure 2F ). This requires additional studies to determine the underlying mechanism. Although tamoxifen injection per se altered myocyte behaviour, its administration was obligatory for the generation of the conditional Ga q KO. Other methods to bypass the tamoxifen treatment including siRNA or adenoviral transfections are no alternatives. In the in-vivo situation, the efficiency of the transfection and the resulting protein knockdown is limited. Despite the fact that single cell culture has majorly advanced recently, 36, 37 whole animal genetic approaches allow the investigation of the intervention in the context of the entire animal, an invaluable advantage.
Sets of genetic combinations
We decided not to compare animals in which KO was primarily induced by tamoxifen injection, but instead used a different molecular determinant for the induction of the KO while maintaining the tamoxifen injection for all experimental settings. We suggested two sets of genetic combinations that are suited to study the role of (Tables 2 and 3) . From those studies, we conclude that basic signalling of Ga q and Ga 11 has to be considered when studying their pathological significance. The effects of a Ga q -KO could either be studied using Cre Table 3 ). Regular back-crossing of two mouse lines could be performed with greater ease when compared with four separate mouse lines. Utilizing the combination of mouse genotypes shown in Table 3 , we re-visited our initial question of the possible contributions of normal Ga q / 11 signalling to the physiological behaviour of ventricular myocytes ( Figure 4 ).
Physiological relevance of Ga q in ventricular myocytes
Transgenic mouse models employing gene KO or knockin of Ga q strongly underpinned its role for cardiac diseases. 13 -16 The hypertrophic response of the heart is accompanied by the growth of the individual myocyte. The size of the myocytes can be estimated by evaluating their cross-sectional dimension in histological samples, by measuring their cell area in wide field microscopy or by assessing their plasma membrane capacitance in electrophysiological experiments. Various papers have reported that the hypertrophic response of the heart is under the control of Ga q /Ga 11 -coupled signalling pathways. 13 -15,38 Our results of the cellular capacitance were in agreement with such studies even without any treatment and interventions. The KO of Ga q and Ga 11 resulted in a reduced capacitance, whereby Ga q -deficient myocytes displayed the largest effect ( Figure 4A) . Furthermore, we report that basic Ga q and Ga 11 signalling are important contributors to the basic physiological properties of cardiac myocytes ( Figure 4) . Additionally, we also demonstrated that Ga 11 KO resulted in altered APs and Ca 2+ handling (Figures 2 and 3) .
Sah et al. 39 described that prolonged AP repolarisation leads to decreased I Ca and decreased cellular Ca 2+ transients. Using slightly different approaches, the same authors also reported opposite effects. 40 This might indicate that the relationship between AP repolarisation duration, I Ca and SR Ca 2+ release is rather complex, which is supported by our results: in Figures 2 and 3, APD 30 was decreased but the amplitude of steady-state Ca 2+ transients remained unchanged (Figure 2Db vs. Fb and Figure 3Db vs. Fb). In Figure 4 , APD 30 was unchanged for all phenotypes but the amplitude of Ca 2+ transients was greatly increased (Figure 4Db vs. Fb). By analysing I Ca in future studies, we might be able to shed light on possible underlying contributors. How do Ga q and Ga 11 proteins mediate changes in gene expression and regulation resulting in altered electrophysiology and Ca 2+ homoeostasis? We believe that the changes were not brought about by the proteins per se, but instead, the results reflect the importance of a constant, possibly low-level stimulation of the upstream G-protein-coupled receptors with agonists coupling to Ga q and/or Ga 11 such as endothelin-1 or angiotensin-II. 41 When stimulated chronically at high levels, G-proteins contribute to cardiac diseases and associated changes in gene expression. 42, 43 In contrast, with persistent stimulation at a much lower hormone level, Ga q -and Ga 11 -coupled signalling pathways appear to be an important contributor to the maintenance of the myocyte's homoeostasis. One of the best known signalling pathway coupled to Ga q -proteins involves Ga q -induced phospholipase C b (PLC b ) activation. This leads to a breakdown of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) into diacylglycerol (a major activator of PKCs) 44 and inositol 1,4,5 triphosphate (InsP 3 ; a major activator of InsP 3 receptors) 45 . InsP 3 itself is discussed as an important mediator of cardiac pathologies. 4, 5, 7 In cardiac myocytes, the plasma membrane levels of PIP 2 itself are potent modulators of ion channels or transporters, such as K ATP channels and NCX 46 (for a recent review see 47 ) . Taking this into account, we hypothesise that the reduced metabolism of PIP 2 in Ga q -deficient myocyte might lead to PIP 2 -dependent deregulation of NCX and thus might contribute to the altered Ca 2+ handling described here.
The identification of important homoeostatic hormones and their downstream signalling appears important but lies well outside of the scope of these reports. Further studies will provide such information that is vital for our understanding of processes that are essential for maintaining a 'physiological' gene expression pattern.
We thus conclude that both Ga q and Ga 11 are instrumental to the physiological properties of cardiac myocytes by mediating the continuance of a basic rate of gene expression.
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Supplementary material is available at Cardiovascular Research online.
